Guardian Pharmacy Service... (GRDN)
Guardian Pharmacy Services Statistics
Share Statistics
Guardian Pharmacy Services has 63.29M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 63.29M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 1.95K |
| FTD / Avg. Volume | 2.37% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -14.39 and the forward PE ratio is null. Guardian Pharmacy Services's PEG ratio is 0.03.
| PE Ratio | -14.39 |
| Forward PE | n/a |
| PS Ratio | 1.02 |
| Forward PS | n/a |
| PB Ratio | 8.81 |
| P/FCF Ratio | 30.2 |
| PEG Ratio | 0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Guardian Pharmacy Services.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.21.
| Current Ratio | 1.05 |
| Quick Ratio | 0.77 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | -0.69 |
| Debt / FCF | 0.72 |
| Interest Coverage | -19.19 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $361.3K |
| Profits Per Employee | $-25.67K |
| Employee Count | 3,400 |
| Asset Turnover | 3.83 |
| Inventory Turnover | 24.27 |
Taxes
| Income Tax | 4.56M |
| Effective Tax Rate | -6.85% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 3.59, so Guardian Pharmacy Services's price volatility has been higher than the market average.
| Beta | 3.59 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 20.82 |
| 200-Day Moving Average | null |
| Relative Strength Index (RSI) | 64.07 |
| Average Volume (20 Days) | 82.12K |
Income Statement
In the last 12 months, Guardian Pharmacy Services had revenue of 1.23B and earned -87.29M in profits. Earnings per share was -1.77.
| Revenue | 1.23B |
| Gross Profit | 244.37M |
| Operating Income | -62.92M |
| Net Income | -87.29M |
| EBITDA | -43.43M |
| EBIT | -63.2M |
| Earnings Per Share (EPS) | -1.77 |
Balance Sheet
The company has 4.66M in cash and 30.13M in debt, giving a net cash position of -25.47M.
| Cash & Cash Equivalents | 4.66M |
| Total Debt | 30.13M |
| Net Cash | -25.47M |
| Retained Earnings | 17.12M |
| Total Assets | 320.81M |
| Working Capital | 7.86M |
Cash Flow
In the last 12 months, operating cash flow was 57.96M and capital expenditures -16.37M, giving a free cash flow of 41.59M.
| Operating Cash Flow | 57.96M |
| Capital Expenditures | -16.37M |
| Free Cash Flow | 41.59M |
| FCF Per Share | 0.67 |
Margins
Gross margin is 19.89%, with operating and profit margins of -5.12% and -7.11%.
| Gross Margin | 19.89% |
| Operating Margin | -5.12% |
| Pretax Margin | -5.41% |
| Profit Margin | -7.11% |
| EBITDA Margin | -3.54% |
| EBIT Margin | -5.12% |
| FCF Margin | 3.39% |
Dividends & Yields
GRDN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for GRDN is $23, which is -4.6% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $23 |
| Price Target Difference | -4.6% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | 8.79 |
| Piotroski F-Score | 6 |